Cytosorbents Corp Files 8-K: Regulation FD Disclosure
Ticker: CTSO · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
TL;DR
CYTOSORBENTS CORP FILED AN 8-K FOR REG FD DISCLOSURE - NO NEW FINANCIALS YET.
AI Summary
Cytosorbents Corporation announced on June 10, 2025, a Regulation FD Disclosure. The filing does not contain specific financial figures or new material events beyond the disclosure itself. The company, incorporated in Delaware, is involved in the surgical and medical instruments and apparatus industry.
Why It Matters
This filing indicates Cytosorbents Corporation is making a public disclosure under Regulation FD, ensuring all investors receive the same material information simultaneously.
Risk Assessment
Risk Level: low — The filing is a standard disclosure and does not contain information that inherently increases or decreases risk.
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant
- June 10, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of incorporation
- 305 College Road East Princeton, New Jersey 08540 (address) — Principal executive offices
- 732-329-8885 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to provide a Regulation FD Disclosure.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is June 10, 2025.
In which state was Cytosorbents Corporation incorporated?
Cytosorbents Corporation was incorporated in Delaware.
What is the company's principal executive office address?
The principal executive offices are located at 305 College Road East, Princeton, New Jersey 08540.
What is the registrant's telephone number?
The registrant's telephone number, including area code, is (732) 329-8885.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Cytosorbents Corp (CTSO).